Transplanting FVIII/ET3-Secreting Cells in Fetal Sheep Increases FVIII Levels Long-Term without Inducing Immunity or Toxicity

Investigators showed that prenatal transplantation of human placental cells bioengineered to produce an optimized FVIII protein, results in considerable elevation in plasma FVIII levels that persists for >three years post-treatment.